Bank of Montreal’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bank of Montreal’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,000	Closed	-$20K	–	4994
2018 Q3	$20K	Sell	6,000 -19,200	-76%	-$69.2K	﹤0.01%	3713
2018 Q2	$95K	Sell	25,200 -95,900	-79%	-$467K	﹤0.01%	3148
2018 Q1	$495K	Buy	121,100 +92,000	+316%	+$428K	﹤0.01%	2232
2017 Q4	$135K	Buy	+29,100	New	+$160K	﹤0.01%	2871
2016 Q2	–	Sell	-2,500	Closed	-$12K	–	4457
2016 Q1	$12K	Hold	2,500	–	–	﹤0.01%	3575
2015 Q4	$13K	Sell	2,500 -9,900	-80%	-$47K	﹤0.01%	3554
2015 Q3	$44K	Buy	+12,400	New	+$83K	﹤0.01%	2977

Bank of Montreal's KERX Position: Q4 2018 in Review

Bank of Montreal sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 6,660 shares — an estimated $22K sold.

Bank of Montreal first reported a position in KERX in Q2 2013 and held it in 19 quarters. The position peaked at $509K in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Bank of Montreal reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Bank of Montreal sold 6,660 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $22K.
Bank of Montreal first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 19 quarters.
Bank of Montreal's Keryx Biopharmaceuticals Inc position peaked at $509K in Q2 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Bank of Montreal's 13F filing for Q4 2018, filed 22 Jan 2019.